IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma

被引:0
|
作者
W J Chng
A Gualberto
R Fonseca
机构
[1] Mayo Clinic Scottsdale,Division of Hematology
[2] Pfizer Global Research and Development,Oncology
来源
Leukemia | 2006年 / 20卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:174 / 176
页数:2
相关论文
共 50 条
  • [1] IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma
    Chng, WJ
    Gualberto, A
    Fonseca, R
    [J]. LEUKEMIA, 2006, 20 (01) : 174 - 176
  • [2] Targeting the IGF-1R signaling and mechanisms for epigenetic gene silencing in human multiple myeloma
    Jernberg-Wiklund, Helena
    Nilsson, Kenneth
    [J]. UPSALA JOURNAL OF MEDICAL SCIENCES, 2012, 117 (02) : 166 - 177
  • [3] Blockade of Peripheral IGF-1R with IGF-1R Antagonist Antibody.
    Kong, M.
    Huffman, D. M.
    Barzilai, N.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 213 - 213
  • [4] Blockade of IGF-1R with OSI-906 Overcomes Bortezomib-Resistance in Multiple Myeloma
    Kuhn, Deborah J.
    Wang, Hua
    Jones, Richard Julian
    Bjorklund, Chad C.
    Orlowski, Robert Z.
    [J]. BLOOD, 2011, 118 (21) : 421 - 421
  • [5] CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity
    Bataille, Regis
    Robillard, Nelly
    Avet-Loiseau, Herve
    Harousseau, Jean-Luc
    Moreaudegrees, Philippe
    [J]. HAEMATOLOGICA, 2005, 90 (05) : 706 - 707
  • [6] The IGF/IGF-1R system is a major therapeutic target for multiple myeloma, other hematologic malignancies and solid tumors.
    Mitsiades, CS
    Mitsiades, N
    Kung, AL
    Shringapurne, R
    Poulaki, V
    Richardson, PG
    Liberman, TA
    Munshi, NC
    Loukopoulos, D
    Anderson, KC
    [J]. BLOOD, 2002, 100 (11) : 170A - 170A
  • [7] IGF-1R inhibitors
    Paz-Ares, Luis
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S150 - S150
  • [8] CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction
    Bruyer, Angelique
    Robert, Nicolas
    Boireau, Stephanie
    Hirtz, Christophe
    Tiers, Laurent
    Vincent, Laure
    Cartron, Guillaume
    Hose, Dirk
    Seckinger, Anja
    Moreaux, Bernard Kleinand Jerome
    [J]. BLOOD, 2017, 130
  • [9] Mechanisms of acquired resistance to an IGF-1R inhibitor in multiple models
    Huang, Fei
    Hurlburt, Warren
    Greer, Ann
    Reeves, Karen A.
    Hillerman, Stephen
    Chang, Han
    Emanuel, Stuart
    Finckenstein, Friedrich
    Gottardis, Marco M.
    Carboni, Joan M.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [10] IGF-1R tyrosine kinase expression and dependency in clones of IGF-1R knockout cells (R-)
    Rosengren, Linda
    Vasilcanu, Daiana
    Vasilcanu, Radu
    Fickenscher, Sandra
    Sehat, Bita
    Natalishvili, Nathalia
    Naughton, Sean
    Yin, Shucheng
    Girnita, Ada
    Girnita, Leonard
    Axelson, Magnus
    Larsson, Olle
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 347 (04) : 1059 - 1066